Glory Health Industry Limited logo

Glory Health Industry Limited

2329.HK

HKSEReal EstateReal Estate - Development

Latest quote

HK$0.103

−HK$0.003 · -2.83%

Aug 24, 4:08 PM HKT

2329.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Glory Health Industry Limited functions as an investment holding company, concentrating its efforts on real estate development within the People's Republic of China. The firm's activities are organized into four principal divisions: Property Development; Primary Land Construction and Development Services; Property Investment; and Property Management and Related Services. Its Property Development segment is responsible for the creation and sale of commercial and residential properties. Through its Primary Land Construction and Development Services unit, the company provides essential land preparation, including resettlement initiatives and the construction of fundamental infrastructure and public facilities on land owned by local governments. The Property Investment division manages properties for rental income, while the Property Management and Related Services segment delivers extensive property administration and related offerings. The company caters to individual purchasers for residential units and various corporations and businesses for its commercial properties. Founded in 1994 and based in Beijing, China, the entity was formerly known as Guorui Properties Limited until its name change to Glory Health Industry Limited in July 2022. It operates as a subsidiary of Alltogether Land Company Limited.

Industry
Real Estate - Development
Sector
Real Estate
Headquarters
CN
CEO
Zhangsun Zhang
Listed since
Jul 7, 2014
Employees
328

Market position

Day range

Current HK$0.103

52-week range

Current HK$0.103

Open
HK$0.096
Previous close
HK$0.106
Volume
194K
0.96× average
Average volume
202.77K
Average daily volume
Market cap
457.78M HKD
Beta
0.38
Market reference 1
50-day average
HK$0.0899
+14.62% above average
200-day average
HK$0.1078
-4.44% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
24.19B CNY
P/E (TTM)
-0.22×
P/B (TTM)
0.05×
P/S (TTM)
0.38×
EV / EBITDA
-34.72×
Earnings yield
-359.47%
Free cash flow yield
3.00%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
-29.75%
Operating margin
-74.43%
Net margin
-175.98%
Return on equity
-22.47%
Return on assets
-3.21%
Return on invested capital
-1.36%

Financial health

Debt / equity
2.94×
Current ratio
0.68×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends40%-38%-117%-196%Gross margin, FY2021: 12.60%Gross margin, FY2022: 2.91%Gross margin, FY2023: -2.01%Gross margin, FY2024: 20.54%Gross margin, FY2025: -29.75%Operating margin, FY2021: 5.01%Operating margin, FY2022: -10.63%Operating margin, FY2023: -18.41%Operating margin, FY2024: 9.12%Operating margin, FY2025: -74.43%Net margin, FY2021: 2.31%Net margin, FY2022: -23.38%Net margin, FY2023: -22.50%Net margin, FY2024: -45.85%Net margin, FY2025: -175.98%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 12.60%. Gross margin FY2022 2.91%. Gross margin FY2023 -2.01%. Gross margin FY2024 20.54%. Gross margin FY2025 -29.75%. Operating margin FY2021 5.01%. Operating margin FY2022 -10.63%. Operating margin FY2023 -18.41%. Operating margin FY2024 9.12%. Operating margin FY2025 -74.43%. Net margin FY2021 2.31%. Net margin FY2022 -23.38%. Net margin FY2023 -22.50%. Net margin FY2024 -45.85%. Net margin FY2025 -175.98%.

Income trends

Revenue

1.04B CNY-61.72%

Operating income

−770.83M CNY−1.02B CNY

Net income

−1.82B CNY-46.92%
Income trends across reported periods11.07B CNY6.38B CNY1.69B CNY−2.99B CNYRevenue, FY2021: 9.9B CNYRevenue, FY2022: 3.9B CNYRevenue, FY2023: 2.51B CNYRevenue, FY2024: 2.71B CNYRevenue, FY2025: 1.04B CNYOperating income, FY2021: 496.02M CNYOperating income, FY2022: −415.14M CNYOperating income, FY2023: −461.41M CNYOperating income, FY2024: 246.7M CNYOperating income, FY2025: −770.83M CNYNet income, FY2021: 228.33M CNYNet income, FY2022: −912.78M CNYNet income, FY2023: −563.97M CNYNet income, FY2024: −1.24B CNYNet income, FY2025: −1.82B CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 9.9B CNY. Revenue FY2022 3.9B CNY. Revenue FY2023 2.51B CNY. Revenue FY2024 2.71B CNY. Revenue FY2025 1.04B CNY. Operating income FY2021 496.02M CNY. Operating income FY2022 −415.14M CNY. Operating income FY2023 −461.41M CNY. Operating income FY2024 246.7M CNY. Operating income FY2025 −770.83M CNY. Net income FY2021 228.33M CNY. Net income FY2022 −912.78M CNY. Net income FY2023 −563.97M CNY. Net income FY2024 −1.24B CNY. Net income FY2025 −1.82B CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue1.04B CNY2.71B CNY2.51B CNY3.9B CNY9.9B CNY
Cost of goods sold1.34B CNY2.15B CNY2.56B CNY3.79B CNY8.65B CNY
Gross profit−308.09M CNY555.56M CNY−50.28M CNY113.52M CNY1.25B CNY
Selling, general, and administrative243.61M CNY277.35M CNY429.87M CNY460.57M CNY667.52M CNY
Operating expenses462.74M CNY308.87M CNY411.13M CNY528.65M CNY751.22M CNY
Interest income243K CNY65.58M CNY73.56M CNY74.26M CNY83.94M CNY
Interest expense847.34M CNY1.06B CNY449.27M CNY451.59M CNY744.91M CNY
Depreciation and amortization73.93M CNY76.58M CNY83.49M CNY89.2M CNY85.53M CNY
Operating income−770.83M CNY246.7M CNY−461.41M CNY−415.14M CNY496.02M CNY
Net income−1.82B CNY−1.24B CNY−563.97M CNY−912.78M CNY228.33M CNY

Company facts updated Aug 24, 2026.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.0376

2020 complete year-37.9% since 2015

Corporate action history

Dividend

Ex-dividend Aug 12, 2020

HK$0.0376

Annual

Record Aug 14, 2020 · Payment Aug 31, 2020

Dividend

Ex-dividend May 30, 2019

HK$0.0564

Annual

Record Jun 1, 2019 · Payment Jun 20, 2019

Dividend

Ex-dividend May 31, 2016

HK$0.055

Annual

Record Jun 1, 2016 · Payment Jun 14, 2016

Dividend

Ex-dividend Jun 2, 2015

HK$0.0605

Annual

Record Jun 3, 2015 · Payment Jun 15, 2015

2329.HK peers

Continue in GoAI

Research 2329.HK

research.disclaimer